NOVO’s client, Bigfoot Biomedical, announced today a Series A investment of $35.5M to support its development of an automated insulin delivery system (sometimes referred to as an “artificial pancreas”)…
The Clinical Chemistry and Clinical Toxicity Devices Panel recommended to the FDA today that in addition to tracking and trending blood glucose concentration, patients should be able to use the Dexcom…
Today, NOVO Engineering announced new officer-level promotions for two of our senior managers. Nora Mead was promoted from her current role as controller to the role of Chief Financial…
Two of NOVO’s clients were recognized at the 2016 San Diego Innovation Night in a showcase featuring groundbreaking technologiesin San Diego County. The event, a fundraiser called “High-Tech Meets…
NOVO Engineering senior management promotions announced today: Kevin Knapp: from Senior Program Manager to General Manager. Kevin joined NOVO in 2013 and has twenty years of leadership experience in…